{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:25:23Z","timestamp":1790774723090,"version":"4.1.0"},"reference-count":24,"publisher":"European Respiratory Society (ERS)","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.ersjournals.com\/user-licence"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2022,10,13]]},"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1183\/13993003.01972-2022","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T09:31:42Z","timestamp":1672997502000},"page":"2201972","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Sotatercept for pulmonary arterial hypertension: something old and something new"],"prefix":"10.1183","volume":"61","author":[{"given":"Lewis J.","family":"Rubin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Naeije","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2023,1,6]]},"reference":[{"key":"2024102012155469000_61.1.2201972.1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01347-2022"},{"key":"2024102012155469000_61.1.2201972.2","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1056\/NEJMoa2024277","article-title":"Sotatercept for the treatment of pulmonary arterial hypertension","volume":"384","author":"Humbert","year":"2021","journal-title":"N Engl J Med"},{"key":"2024102012155469000_61.1.2201972.3","doi-asserted-by":"crossref","first-page":"eeaz5660","DOI":"10.1126\/scitranslmed.aaz5660","article-title":"ACTRIIA-Fc rebalances activin\/GDF versus BMP signaling in pulmonary hypertension","volume":"12","author":"Yung","year":"2020","journal-title":"Sci Transl Med"},{"key":"2024102012155469000_61.1.2201972.4","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1164\/rccm.202009-3698OC","article-title":"Association between initial treatment strategy and long-term survival in pulmonary arterial hypertension","volume":"204","author":"Boucly","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102012155469000_61.1.2201972.5","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01889-2018"},{"key":"2024102012155469000_61.1.2201972.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1503184"},{"key":"2024102012155469000_61.1.2201972.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.10.034"},{"key":"2024102012155469000_61.1.2201972.8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.029254"},{"key":"2024102012155469000_61.1.2201972.9","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201105-0848OC"},{"key":"2024102012155469000_61.1.2201972.10","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1183\/13993003.02334-2021","article-title":"The physiological basis of pulmonary arterial hypertension","volume":"59","author":"Naeije","year":"2022","journal-title":"Eur Respir J"},{"key":"2024102012155469000_61.1.2201972.11","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.165.3.2106033"},{"key":"2024102012155469000_61.1.2201972.12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12968-021-00743-2","article-title":"Multimodal assessment of right ventricle overload-metabolic and clinical consequences in pulmonary arterial hypertension","volume":"23","author":"Kazimierczyk","year":"2021","journal-title":"J Cardiovasc Magn Reson"},{"key":"2024102012155469000_61.1.2201972.13","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01900-2018"},{"key":"2024102012155469000_61.1.2201972.14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.healun.2017.08.009","article-title":"Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertension","volume":"37","author":"Badagliacca","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"2024102012155469000_61.1.2201972.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2020.04.005"},{"key":"2024102012155469000_61.1.2201972.16","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1164\/rccm.202109-2079PP","article-title":"Aggressive afterload lowering to improve the right ventricle: a new target for medical therapy in pulmonary arterial hypertension?","volume":"205","author":"Vizza","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102012155469000_61.1.2201972.17","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1164\/rccm.202004-1006OC","article-title":"Risk reduction and hemodynamics with initial combination therapy in pulmonary arterial hypertension","volume":"203","author":"Badagliacca","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102012155469000_61.1.2201972.18","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.healun.2020.08.016","article-title":"Hemodynamics and risk assessment 2 years after the initiation of upfront ambrisentan\u2013tadalafil in pulmonary arterial hypertension","volume":"39","author":"D'Alto","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"2024102012155469000_61.1.2201972.19","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.chest.2019.09.009","article-title":"Risk reduction and right heart reverse remodeling by upfront triple combination therapy in pulmonary arterial hypertension","volume":"157","author":"D'Alto","year":"2020","journal-title":"Chest"},{"key":"2024102012155469000_61.1.2201972.20","doi-asserted-by":"crossref","first-page":"107099","DOI":"10.1016\/j.vph.2022.107099","article-title":"Pulmonary pressure normalization in idiopathic, hereditary drug- and toxin-induced pulmonary arterial hypertension. Determinants and clinical impact","volume":"146","author":"Badagliacca","year":"2022","journal-title":"Vasc Pharmacol"},{"key":"2024102012155469000_61.1.2201972.21","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S0022-5223(19)32540-1","article-title":"The regression of pulmonary vascular disease after the creation of pulmonary stenosis","volume":"42","author":"Dammann","year":"1961","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2024102012155469000_61.1.2201972.22","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0022-5223(19)38415-6","article-title":"Reversibility of plexogenic pulmonary arteriopathy following banding of the pulmonary artery","volume":"87","author":"Wagenvoort","year":"1984","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2024102012155469000_61.1.2201972.23","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvw070"},{"key":"2024102012155469000_61.1.2201972.24","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-2498(00)00153-4"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.01972-2022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T06:12:43Z","timestamp":1740377563000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.01972-2022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1,6]]},"published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.1183\/13993003.01972-2022"],"URL":"https:\/\/doi.org\/10.1183\/13993003.01972-2022","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]}}}